Cadre Holdings, Inc.
CDRE- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001860543
In the last 90 days, Cadre Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $944.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Cadre Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $9.47M in total
- Insiders trading
- 2
- Net value
- −$9.47M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Cadre Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kanders Warren B | CEO AND CHAIRMAN | 9,417,039Indirect | Aug 26, 2026 | 11 |
| Williams Brad | PRESIDENT | 65,081 | Aug 19, 2026 | 9 |
| Sokolow Nicolas | Director | 79,231Indirect | Jun 18, 2026 | 1 |
| Quigley William G III | Director | 23,500 | Jun 18, 2026 | 1 |
| Norton Hamish | Director | 23,500 | Jun 18, 2026 | 1 |
| Browers Blaine | CHIEF FINANCIAL OFFICER | 69,653 | Jun 18, 2026 | 5 |
| Kissel Mary E. | Director | – | Jun 18, 2026 | 1 |
| DeCotis Deborah A | Director | – | Jun 3, 2025 | 0 |
| Delzanno Gianmaria C | Director | – | Jun 3, 2025 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 (view filing) | Dec 12 | 4 days | Browers BlaineCHIEF FINANCIAL OFFICER | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −20.4K | $43.79 | −$894.8K | −24.5%63.1K after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Kanders Warren BCEO AND CHAIRMAN | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −100.0K | $31.40 | −$3.14M | −1.0%10.0M after | |
| Mar 24, 2026 (view filing) | Mar 23 | 1 day | Kanders Warren BCEO AND CHAIRMAN | SSale | −100.0K | $31.93 | −$3.19M | −1.0%9.92M after | |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Kanders Warren BCEO AND CHAIRMAN | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −100.0K | $30.03 | −$3.00M | −1.0%9.82M after | |
| Jun 17, 2026 (view filing) | Jun 16-17 | 1 day | Kanders Warren BCEO AND CHAIRMAN | SSale | −125.0K | $28.29 | −$3.54M | −1.3%9.69M after | 2 lots |
| Jun 23, 2026 (view filing) | Jun 18 | 5 days | Kanders Warren BCEO AND CHAIRMAN | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −25.0K | $27.86 | −$696.5K | −0.3%9.67M after | |
| Jun 23, 2026 (view filing) | Jun 22 | 1 day | Kanders Warren BCEO AND CHAIRMAN | SSale | −50.0K | $27.43 | −$1.37M | −0.5%9.62M after | |
| Aug 19, 2026 (view filing)4:15 PM ET | Aug 17 | 2 days | Williams BradPRESIDENT | SSale | −88.7K | $33.24 | −$2.95M | −57.7%65.1K after | 2 lots |
| Aug 26, 2026 (view filing)4:15 PM ET | Aug 24 | 2 days | Kanders Warren BCEO AND CHAIRMAN | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −65.4K | $33.20 | −$2.17M | −0.7%9.55M after | |
| Aug 26, 2026 (view filing)4:15 PM ET | Aug 24-25 | 2 days | Kanders Warren BCEO AND CHAIRMAN | SSale | −134.6K | $32.33 | −$4.35M | −1.4%9.42M after | 3 lots |